Solution structure of a 2:1 C2-(2-naphthyl) pyrrolo[2,1-c][1,4]benzodiazepine DNA adduct: molecular basis for

Dyeison Antonow1, Teresa Barata, Terence C Jenkins

  • 1Gene Targeting Drug Design Research Group, Spirogen Ltd., and The School of Pharmacy, University of London, 29/39 Brunswick Square, London, UK.

Biochemistry
|October 18, 2008
PubMed